Latest Advances in Anti-TNF Therapies in Rheumatoid Arthritis
hosted byPrime Education, LLCLatest Advances in Anti-TNF Therapies in Rheumatoid Arthritis is organized by Prime Education, LLC.
Release Date: July 28, 2023
Expiration Date: July 27, 2024
Description:
For patients with moderate to severe rheumatoid arthritis (RA), anti-TNF biologics provide a cornerstone for enhancing outcomes. Now, advancements in therapy formulations and clinical evidence empower healthcare providers with more options to personalize treatment plans. Join this engaging video to keep up-to-date on the latest evidence in the field of anti-TNF therapies. Expert faculty will discuss pivotal data and key differences among the treatments and will challenge learners with interactive polling questions throughout the program.
Learning Objectives:
• Evaluate the latest efficacy and safety data from clinical trials and real-world studies of newer anti-TNF therapies for rheumatoid arthritis
• Differentiate new and emerging anti-TNF therapy formulations for rheumatoid arthritis
Agenda:
• Key Clinical Trial and Real-World Data Supporting the Safety and Efficacy of Infliximab, Etanercept, and Adalimumab Therapies in Patients With RA
• Differentiating Anti-TNF Therapy Formulations
